Using HIV clinics in Zambia to provide cervical cancer prevention through HPV vaccination
Leveraging HIV infrastructure to implement cervical cancer prevention: A study to integrate HPV vaccination in adolescent HIV clinics in Zambia
This study is working to make it easier for girls aged 9-14 who visit HIV clinics in Zambia to get the HPV vaccine, which helps protect against cervical cancer, by finding the best ways to include local customs and practices in the vaccination process.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11089017 on NIH RePORTER |
What this research studies
This research aims to improve access to the HPV vaccine for adolescents attending HIV clinics in Zambia, where cervical cancer risk is high. By leveraging existing healthcare infrastructure, the project will implement strategies to increase vaccination rates among girls aged 9-14. The study will focus on understanding how to effectively integrate equity and decolonization practices into the implementation of the HPV vaccination program. This approach will involve collaboration with local teams to ensure that the methods are culturally appropriate and effective.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescent girls aged 9-14 who are attending HIV clinics in Zambia.
Not a fit: Patients who are not within the target age group or who do not attend the specified clinics may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of cervical cancer among young women in Zambia by increasing HPV vaccination rates.
How similar studies have performed: Other research has shown success in implementing vaccination programs in similar contexts, but this specific approach focusing on equity and decolonization is relatively novel.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Hunleth, Jean Marie — Washington University
- Study coordinator: Hunleth, Jean Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.